-+ 0.00%
-+ 0.00%
-+ 0.00%

Bone Biologics Q3 EPS $(0.17) Beats $(0.18) Estimate

Benzinga·10/26/2026 21:36:24
Listen to the news
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) by 5.56 percent. This is a 54.05 percent increase over losses of $(0.37) per share from the same period last year.